Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway
See allHide authors and affiliations
Edited by Robert Haselkorn, University of Chicago, Chicago, IL, and approved March 25, 2014 (received for review November 7, 2013)

Significance
New antifungal compounds are needed due to an increasing incidence of invasive fungal infections and resistance to many currently used drugs. Here we show that cyanobacteria are a rich source of antifungal compounds such as glycosylated lipopeptides, called hassallidins, which are commonly produced by filamentous nitrogen-fixing cyanobacteria. A diverse group of hassallidins and their complex nonribosomal biosynthesis were characterized in detail. Hassallidins and their previously unidentified biosynthetic enzymes offer new material for drug development. In addition, these compounds may have an ecological role in protecting cyanobacteria from parasitic fungi.
Abstract
Cyanobacteria produce a wide variety of cyclic peptides, including the widespread hepatotoxins microcystins and nodularins. Another class of peptides, cyclic glycosylated lipopeptides called hassallidins, show antifungal activity. Previously, two hassallidins (A and B) were reported from an epilithic cyanobacterium Hassallia sp. and found to be active against opportunistic human pathogenic fungi. Bioinformatic analysis of the Anabaena sp. 90 genome identified a 59-kb cryptic inactive nonribosomal peptide synthetase gene cluster proposed to be responsible for hassallidin biosynthesis. Here we describe the hassallidin biosynthetic pathway from Anabaena sp. SYKE748A, as well as the large chemical variation and common occurrence of hassallidins in filamentous cyanobacteria. Analysis demonstrated that 20 strains of the genus Anabaena carry hassallidin synthetase genes and produce a multitude of hassallidin variants that exhibit activity against Candida albicans. The compounds discovered here were distinct from previously reported hassallidins A and B. The IC50 of hassallidin D was 0.29–1.0 µM against Candida strains. A large variation in amino acids, sugars, their degree of acetylation, and fatty acid side chain length was detected. In addition, hassallidins were detected in other cyanobacteria including Aphanizomenon, Cylindrospermopsis raciborskii, Nostoc, and Tolypothrix. These compounds may protect some of the most important bloom-forming and globally distributed cyanobacteria against attacks by parasitic fungi.
- nonribosomal peptide synthesis
- natural product discovery
- genome mining
- secondary metabolites
- bioactive peptide
Footnotes
- ↵1To whom correspondence should be addressed. E-mail: kaarina.sivonen{at}helsinki.fi.
Author contributions: J.V., T.K.S., J.J., D.P.F., L.R., and K.S. designed research; J.V., T.K.S., J.J., D.P.F., O.A., M.W., H.W., and L.R. performed research; P.P. and K.S. contributed new reagents/analytic tools; J.V., T.K.S., J.J., D.P.F., O.A., M.W., H.W., and L.R. analyzed data; and J.V., T.K.S., J.J., D.P.F., P.P., H.W., L.R., and K.S. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Data deposition: The sequence reported in this paper has been deposited in the GenBank database (accession nos. KJ502174, KF631395, KF631396, KF631397, KF631398, and KF631399.).
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1320913111/-/DCSupplemental.
Freely available online through the PNAS open access option.
Citation Manager Formats
Article Classifications
- Biological Sciences
- Microbiology